Dr. Otello Stampacchia is a globetrotter of the first order, traveling around the world as the head of investor relations and strategic initiatives for his firm Omega Funds. He is heavily involved in several of Omega’s therapeutic areas of interest, particularly oncology and inflammatory disorders. Omega’s investments have resulted in over 50 life changing drugs, approved and on market. Join us as we talk about various aspects of the ever-changing health care industry with a scientist/investor who is tops in his field!
